Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.19 +0.00 (+0.00%)
As of: Oct 5, 2026 · 3:45 PM EDT

Drugs Made In America Acquisition (DMII) Other Non-Current Assets (2024)

Updated

Drugs Made In America Acquisition (DMII) reported Other Non-Current Assets of $78,449 for Q4 2024.

Analysis

Drugs Made In America Acquisition (DMII) Other Non-Current Assets (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 BlackRock 164.13 Bn 110.49 Bn - 7.49 Bn
2 Spdr Gold Trust 133.82 Bn -424.18 Bn - -
3 Blackstone 84.08 Bn 79.01 Bn - 996.51 Mn
4 Brookfield 82.97 Bn -82.41 Bn 4.47 Bn 48.59 Bn
5 Kkr 81.05 Bn 47.53 Bn - 13.17 Bn
6 Brookfield Asset Management 71.64 Bn 67.88 Bn - -
7 Apollo Global Management 65.67 Bn 3.35 Bn 10.56 Bn 15.06 Bn
8 Wheaton Precious Metals 61.89 Bn 57.32 Bn 687.86 Mn -
9 Franco Nevada 46.13 Bn 43.49 Bn 451.00 Mn 20.50 Mn
10 Drugs Made In America Acquisition 649.10 Mn 649.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 78,449.00
API Access

Drugs Made In America Acquisition Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=DMII&period=max&api_key=YOUR_API_KEY